Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1998

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Cerebral sinus thrombosis and oral contraceptives. There are limits to

predictability [editorial]

AUTHORS

Vandenbroucke JP

SOURCE

BMJ (CLINICAL RESEARCH ED.). 1998 Aug 22;317(7157):483-4.

ABSTRACT

Two recently published studies have documented a very high relative risk of cerebral sinus thrombosis in oral

contraceptive (OC) users and an even stronger adverse effect among women with hereditary prothrombotic conditions.

Unlike deep venous thrombosis or pulmonary embolism, which are affected by several other risk factors (e.g.,

obesity, trauma, immobilization), cerebral sinus thrombosis may be caused almost entirely by general circulating

factors in the blood. In healthy, nonpregnant, nonmenopausal women, OC use may be the only salient risk factor for

cerebral sinus thrombosis. It has been suggested that screening for prothrombotic deficits should be conducted

before OCs are prescribed. However, even if screening costs were reduced to levels where they were lower than the

medical costs associated with detected cases, the issues of loss of an effective contraceptive option (with

subsequent pregnancy-related health risks) and the psychological impact of knowing one carries a potentially life-

threatening gene remain problematic. (PubHealth.info Document ID: CONT1T 4585-06)

PubHealth.info NOTE: The author(s) of this article titled, "Cerebral sinus thrombosis and oral contraceptives. There

are limits to predictability [editorial]", is(are) Vandenbroucke JP. The source of this article is "BMJ (CLINICAL

RESEARCH ED.). 1998 Aug 22;317(7157):483-4.". This article was published in 1998 in English language(s).

(PubHealth.info® Document ID: CONT1T 4585-06. All rights reserved with PubHealth.info) PIN: 4585

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.